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Abstract
Salmonella enterica replicates in macrophages through the action of effector proteins trans-
located across the vacuolar membrane by a type III secretion system (T3SS). Here we
show that the SPI-2 T3SS effector SpvD suppresses proinflammatory immune responses.
SpvD prevented activation of an NF-κB-dependent promoter and caused nuclear accumula-
tion of importin-α, which is required for nuclear import of p65. SpvD interacted specifically
with the exportin Xpo2, which mediates nuclear-cytoplasmic recycling of importins. We pro-
pose that interaction between SpvD and Xpo2 disrupts the normal recycling of importin-α
from the nucleus, leading to a defect in nuclear translocation of p65 and inhibition of activa-
tion of NF-κB regulated promoters. SpvD down-regulated pro-inflammatory responses and
contributed to systemic growth of bacteria in mice. This work shows that a bacterial patho-
gen can manipulate host cell immune responses by interfering with the nuclear transport
machinery.
Author Summary
Salmonella Typhimurium replicates in macrophages through the action of effector pro-
teins translocated into host cells by a type III secretion system (T3SS). We show that the
T3SS effector SpvD targets the NF-κB pathway by interfering with nuclear translocation of
p65. SpvD interacts with the exportin Xpo2. Perturbation of Xpo2 disrupts recycling of
importin-α from the nucleus, leading to abrogation of p65 nuclear translocation. These
data show that a bacterial pathogen manipulates host cell immune responses by interfering
with nuclear transport machinery.
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Introduction
The NF-κB signalling pathway has a central role in the host response to infection by microbial
pathogens, by stimulating innate and acquired host immune responses. Under normal physio-
logical conditions, transcription factors of the NF-κB family such as p65 remain inactive in the
cytoplasm through their interaction with inhibitors, the IκBα proteins, which mask the nuclear
localisation signal (NLS) of transcription factors. Following engagement of extracellular bacte-
rial LPS by Toll-Like Receptor 4 (TLR4) or tumour necrosis factor (TNF) by the TNF receptor
(TFNR), different pathways lead to phosphorylation and proteasomal degradation of IκBα,
allowing the NF-κB subunits to bind the adaptor protein importin-α (KPNA). This complex
then interacts with one of up to 20 importin-β family members to enable nuclear transport
through the nuclear pore complex. Within the nucleus, RanGTP binds to importin-β, dissoci-
ating the import complex and releasing the NF-κB subunits to initiate transcription of their
target genes. Importin-β complexed with RanGTP is recycled to the cytoplasm while export of
KPNA follows its interaction with the β-karyopherin exportin-2 (Xpo2, also called CAS) and
RanGTP. Finally, cytoplasmic Ran GTPase activating protein (RanGAP) stimulates the Ran
GTPase, generating RanGDP, which dissociates from the importins and thereby releases them
for another import cycle [1,2].
Many pathogens, including Salmonella enterica, have acquired mechanisms that interfere
with NF-κB signalling. Numerous components of the NF-κB signalling pathway are targeted
by pathogen-mediated post-translational modifications (PTMs) that result in attenuation of
the NF-κB dependent responses [3–9].
Salmonella has two type III secretion systems (T3SS) encoded within the Salmonella patho-
genicity islands (SPIs) 1 and 2 that deliver virulence effector proteins into the host cell. The
SPI-1 T3SS effectors are translocated across epithelial cell plasma membranes and mediate bac-
terial invasion and intestinal inflammation [10], while the SPI-2 T3SS translocates approxi-
mately 30 different effectors across the vacuolar membrane. Some of these maintain vacuolar
membrane integrity and enable bacterial growth [11,12]. A few have been shown to interfere
with host cell inflammatory responses. For example, SpvC has phosphothreonine lyase activity
on MAPKs [13,14], SspH1 (translocated both by SPI-1 and SPI-2 T3SSs [15]) binds to the
kinase PKN1 [16], which in turn regulates NF-κB and JNK signalling and AvrA (also translo-
cated both by SPI-1 and SPI-2 T3SSs [17] inhibits NF-κB pathway in epithelial cells [18] via
the JNK pathway [19] and tight junction stabilization [20]. PipA, GogA and GtgA redundantly
target components of the NF-κB signaling pathway to inhibit transcriptional responses leading
to inflammation [21].
Here, we used macrophages lacking TLR4 to reveal that the SPI-2 T3SS effector SpvD sup-
pressed production of pro-inflammatory cytokines. We found that SpvD interfered with the
NF-κB signalling pathway by preventing nuclear accumulation of p65. This was associated
with nuclear accumulation of importin-α family members that are required for nuclear import
of p65. Interestingly, SpvD interacted specifically with exportin Xpo2, which mediates nuclear-
cytoplasmic recycling of importins. Together, this work reveals that a bacterial pathogen pre-
vents host cell immune responses by interfering with nuclear transport machinery.
Results
Suppression of proinflammatory immune responses by SPI-2 T3SS
effectors
We previously reported increases of more than 10-fold in mRNA for 26 genes in wild-type
mouse bone marrow-derived macrophages (BMM) infected for 10 h by S. Typhimurium [22].
SpvD Inhibits Nuclear Transport of p65
PLOS Pathogens | DOI:10.1371/journal.ppat.1005653 May 27, 2016 2 / 26
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Many of these are likely to be due to the predominant effect of LPS on pro-inflammatory sig-
nalling pathways, since LPS and Salmonella cells induced similar changes in RAW 264.7 mac-
rophages gene expression at 4 h post-challenge [23]. To analyse the effect of the SPI-2 T3SS in
the context of TLR4-induced responses, we selected three genes (tnf-α, il1-β and serpinB2) that
are induced by LPS [23,24]. Their mRNA levels were measured in BMM from wild-type and
TLR4 knock-out (TLR4-/-) mice, infected with wild-type or ΔssaV (SPI-2 T3SS null mutant) S.
Typhimurium for 10 h to allow sufficient time for SPI-2 T3SS effector translocation and activ-
ity, while minimising the difference in overall intracellular growth rate between wild-type and
ΔssaVmutant bacteria. The fold-increase in intracellular bacterial numbers (calculated from
the ratio of the cfu at 10 h compared to 2 h post-uptake) was 2.20 ± 0.34 for the wild-type and
0.89 ± 0.09 for ΔssaVmutant bacteria. Following infection of wild-type BMM for 10 h, the
RNA levels of tnf-α, il1-β and serpinB2 (quantified by real-time PCR (qRT-PCR)) increased by
between 40 and 400 fold, and no significant differences were observed between BMM infected
with wild-type or ΔssaVmutant bacteria (Fig 1A and 1B, S1 Fig). Similar increases were
detected following exposure of wild-type BMM to LPS, suggesting that TLR4 signalling
accounted for the majority of these changes (Fig 1A and 1B, S1 Fig). However, TLR4-/- BMM
infected with the ΔssaVmutant had statistically significant higher levels of tnf-α and il1-β
mRNA transcripts than BMM infected with wild-type bacteria (Fig 1A and 1B). No difference
was observed for serpinB2mRNA transcripts levels (S1 Fig), indicating that transcription of
not all the LPS-responsive genes was affected by the SPI2-T3SS. Levels of secreted TNF-α from
TLR4-/- BMM infected with SPI-2 null mutants (ΔssaV or ΔsseB) were also significantly greater
than from TLR4-/- BMM infected with wild-type bacteria or a complemented SPI-2 null mutant
(ΔsseB, psseB) (Fig 1C). The level of secreted Il1-β was below the threshold of detection at 10 h
post-bacterial uptake but was also reduced in a SPI-2 T3SS-dependent manner at 24 h post-
bacterial uptake (Fig 1D). Together these results provide evidence that the SPI-2 T3SS sup-
presses pro-inflammatory cytokine mRNA levels and protein secretion in TLR4-/- macro-
phages. The failure to detect such differences using wild-type BMM presumably reflects the
potent effect of LPS on pro-inflammatory signalling pathways in this experimental system.
SpvD is a SPI-2 T3SS effector suppressing cytokine secretion
To identify SPI-2 T3SS effector(s) involved in down-regulation of pro-inflammatory immune
responses, several SPI-2 T3SS mutant strains (representing single mutants lacking individual
effectors) [25] were screened for levels of secreted TNF-α from TLR4-/- BMM at 10 h post-uptake
(S1 Table). Of these, 2 strains (ΔspvC and ΔspvD) induced significantly more cytokine secretion
from infected BMM compared to BMM infected by the wild-type strain (Fig 1E and 1F). SpvC
and SpvD are encoded by the spvRD operon (composed of spvA, B, C andD, and regulated by
spvR [26] on the Salmonella virulence plasmid (pSLT)) and SpvC is a phosphothreonine lyase
that interferes with MAPK signalling [14]. BMM infected with deletion mutants carrying the low
copy number plasmid pACYC184 containing the corresponding wild-type allele of the gene
(ΔspvC, pspvC or ΔspvD, pspvD) produced significantly less TNF-α and Il1-β than BMM infected
with the single mutant strains (Fig 1E and 1F). To analyse if the effects of SpvD are confined to
macrophages, Hela cells were infected with Salmonella strains for 8, 12 or 24 h and levels of IL-8
in supernatants were quantified by ELISA. Infection with wild-type bacteria induced IL-8 pro-
duction but no increased production was detected in cells infected with the ΔspvDmutant or the
ΔspvCmutant (as shown in [14]) (S2 Fig). However, cells infected with the ΔspvD, pspvD or
ΔspvC, pspvC strains showed significantly less IL-8 production compared with the wild-type
strain at all time-points tested (P 0.05 for all time points). Therefore, the effects of SpvD occur
both in macrophages and another cell type that does not normally respond to LPS.
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Fig 1. The SPI-2 T3SS reduces pro-inflammatory cytokinemRNA levels and protein secretion in TLR4-/- BMM.
Wild-type and TLR4-/- BMMs were non-infected (NI), exposed to LPS (100 ng/ml) or infected with wild-type or ΔssaV
strains for 10 h and mRNA levels of tnf-α (A) and il-1β (B) were analysed. The transcript levels were normalized to the
levels of rsp9, which were constant under all conditions used, and then expressed relative to those of NI wild-type BMMs.
Results are expressed as mean ± SEM of at least 3 independent experiments. Levels of secreted TNF-α (C) and Il-1β (D)
were quantified by ELISA in supernatants of non-infected (NI) TLR4-/- BMMs, TLR4-/- BMMs stimulated with LPS or
TLR4-/- BMMs infected with indicated strains of S. Typhimurium at 10 h or 24 h post-uptake respectively. Results
presented are the means ± SEM of triplicates of one experiment. These results are representative of three independent
experiments and significant differences were observed in each experiment. P-values were obtained using two-tailed
unpaired Student's t-test (*p < 0.05). Levels of secreted TNF-α at 10 h post-uptake (E) and Il-1β at 24 h post-uptake (F)
were quantified by ELISA in supernatants of TLR4-/- BMMs infected with indicated strains of S. Typhimurium. The
cytokine levels were expressed relative to those of BMMs infected with wild-type bacteria. Results are expressed as
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SPI-2 T3SS-dependent secretion of SpvD into minimal medium and its translocation into
host cells (using a CyaA fusion protein) were shown previously [29]; however its function is
unknown and its contribution to virulence of S. Typhimurium in mice is not clear [27–30]. To
confirm SPI-2 T3SS-dependent secretion and translocation of SpvD, strains producing double-
HA tagged SpvD from pSLT were used for an in vitro secretion assay and for macrophage
infection. Secretion of SpvD-2HA from bacteria grown in minimal medium was investigated
following shift of ambient pH from 5.0 to 7.2, which stimulates effector secretion from the SPI-
2 T3SS [31]. A similar amount of SpvD-2HA was present in lysates from wild-type and ΔssaV
mutant bacteria (S3A Fig). SpvD-2HA was also detected in the secreted fraction from wild-
type bacteria but not from the ΔssaVmutant. To investigate SpvD translocation into host cells,
RAWmacrophages were infected for 22 h with Salmonella strains producing SpvD-2HA. Cells
were then fixed and labelled to detect Salmonella and the HA tag. Translocated SpvD-2HA was
not detected within infected macrophages by immunofluorescence microscopy under these
conditions. However when cells were incubated for 2 h prior to fixation with the proteasome
inhibitor MG132, weak but distinct and reproducible cytoplasmic labelling of SpvD-2HA was
detected in the cytoplasm of the majority of cells infected with wild-type but not ΔssaVmutant
Salmonella (S3B Fig). These results suggest that relatively small amounts of SpvD are translo-
cated into the host cell cytoplasm.
Since SpvC inhibits MAP kinase signalling [14] we tested if SpvD affects this pathway in
cells expressing a luciferase reporter gene under the control of MAPK-dependent AP-1 binding
sequences. HEK 293 cells were co-transfected with vectors expressing myc-SpvD or myc-SpvC
(as positive control) or myc vector alone (empty pRK5 vector), along with vector expressing
the luciferase reporter under the control of AP-1 promoter and vector constitutively expressing
the Renilla luciferase, as an internal control for normalisation of data. Cells were exposed to
PMA for 6 h to stimulate MAP kinase pathways. Then cells were lysed and bioluminescence
was measured to determine the fold-difference of MAP kinase activation in relation to non-
transfected cells. Immunoblots of cell lysates following SDS-PAGE, using anti-myc and anti-
tubulin antibodies, confirmed that similar numbers of cells expressing similar levels of effectors
were analysed. Ectopic expression of SpvC resulted in a strong inhibition of luciferase activity,
while transfection of empty vector or of vector producing SpvD did not inhibit luciferase activ-
ity (Fig 2A), suggesting that unlike SpvC, SpvD does not inhibit the MAP kinase signalling
pathway.
SpvD prevents nuclear accumulation of p65
Some T3SS effectors inhibit pro-inflammatory cytokine production and secretion by interfer-
ing with proteins of the NF-κB pathway [6]. To determine the potential effect of SpvD on
nuclear translocation of the NF-κB transcription factor p65, confocal microscopy was used to
quantify the amounts of nuclear p65 in TLR4-/- BMM infected with different Salmonella strains
at 10 h post-bacterial uptake. Cells were immunolabelled with anti-Salmonella and anti-p65
antibodies and nuclei were stained with the DNA dye, DRAQ5 (Fig 2B). Three-dimensional
image projections were acquired randomly and nuclear p65 intensity was quantified using
Volocity software. The intensity of p65 in the nuclei of infected TLR4-/- BMM was significantly
increased when SpvD was absent (ΔspvD, ΔspvRD (corresponding to ΔspvR-spvA-spvB-spvC-
spvDmutant strain) or ΔspvRD,pspvC strains) and was restored to wild-type levels by mutants
carrying pspvD (ΔspvD,pspvD or ΔspvRD,pspvD strains) (Fig 2C), indicating that of spv-
mean ± SEM of at least 3 independent experiments. Statistical significances were calculated using ANOVA followed by
Bonferonni's multiple comparison test against wild-type strain.
doi:10.1371/journal.ppat.1005653.g001
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Fig 2. SpvD prevents nuclear accumulation of p65 but not degradation of IκBα. (A) SpvD does not inhibit activation of
an AP-1-regulated promoter. HEK-293 cells were cotransfected with an AP-1-dependent luciferase reporter plasmid,
pTK-Renilla luciferase and pRK5myc, pRK5myc-SpvC or pRK5myc-SpvD. Cells were then stimulated with PMA for 6 h.
Firefly luciferase activity was normalized against Renilla luciferase activity. Results are expressed as fold induction
compared to non-transfected (NT) cells. Values are expressed as mean ± SEM of 3 independent experiments and P-
values were obtained using two-tailed unpaired Student's t-test (*** p < 0.005). (B-C) SpvD prevents nuclear translocation
of p65. (B) Representative immunofluorescence fields of p65 localisation using anti-p65 (red) in TLR4-/- BMMs infected for
10 h with indicated Salmonella strains (blue). Cell nuclei were stained with DRAQ5 (green). Scale bar, 8 μm. (C)
Quantification above background levels of p65 intensity in the nucleus was analyzed by three-dimensional (3D) confocal
SpvD Inhibits Nuclear Transport of p65
PLOS Pathogens | DOI:10.1371/journal.ppat.1005653 May 27, 2016 6 / 26
encoded proteins, only SpvD prevents nuclear accumulation of p65. NleC, a T3SS effector of
enteropathogenic E. coli is a protease that cleaves p65 directly [32–35]. Therefore, we analysed
total cell levels of p65 in TLR4-/- BMM infected with different Salmonella strains at 10 h post-
uptake. No significant differences were detected (S4A Fig). To determine if the influence of
SpvD on p65 localisation was cell-type specific, its effects on p65 and its localisation were ana-
lysed during infection of HeLa epithelial cells. The amount of p65 in total cell lysates and in
nuclei of HeLa cells infected with Salmonella strains was quantified by immunoblot after cell
fractionation. No differences were detected in total cell extracts, but the amount of p65 in the
nuclei of cells infected with the ΔspvDmutant was consistently increased compared to wild-
type infected cells (S4B Fig). The amount of nuclear p65 was restored to wild-type levels in
cells infected with the ΔspvDmutant carrying a plasmid containing spvD (S4B Fig). In addi-
tion, total levels of p65 in HeLa cells transfected with pRK5myc-SpvD, pRK5myc-SpvC (used
as a negative control) or pRK5myc-NleC (used as a positive control) were analysed by FACS
after labelling of the cells with anti-p65 and anti-myc antibodies. Levels of p65 were determined
in myc-positive cells and normalised to non-transfected cells. Degradation of p65 occurred
only in cells expressing NleC (S4C and S4D Fig). These results indicate that SpvD reduces
nuclear translocation of p65 in both mouse macrophages and human epithelial cells, but does
not affect the overall cellular pool of p65. The amounts of two other immune related transcrip-
tion factors (p50 and STAT2) in total cell lysates and in nuclei of HeLa cells infected with Sal-
monella strains were quantified by immunoblot after cell fractionation. No differences were
detected in total cell extracts, but the amount of p50 in the nuclei of cells infected with the
ΔspvDmutant was consistently increased compared to wild-type -infected cells (S4B Fig). The
amount of nuclear p50 was restored to wild-type levels in cells infected with the ΔspvDmutant
carrying a plasmid containing spvD. No differences in STAT2 levels in nuclei or total cell
lysates were detected. These results indicate that SpvD specifically targets the import of NF-κB
-associated proteins.
The predicted product of spvD is a hydrophilic protein of 216 amino acids [36] and visual
alignment of a region of SpvD with several prokaryotic phosphothreonine lyases [37] revealed
a region in SpvD (between amino acids 181 to 213) that is conserved among these enzymes
(S4E Fig). This area contains an invariant Lys residue (K185) and mutation of this residue in
SpvC results in a loss of phosphothreonine lyase activity [38]. As a further test of the effect of
SpvD on the NF-κB signalling pathway, and to investigate the importance of K185, HEK 293
cells were co-transfected with a reporter plasmid encoding luciferase under the control of NF-
κB promoter and a plasmid encoding either myc alone (empty pRK5 vector), myc-SpvC (as a
negative control), myc-SpvD or myc-SpvDK185A (SpvD carrying a lysine-to-alanine substitu-
tion at residue 185). Luciferase activity was assayed 8 h after TNF-α stimulation and normal-
ised to non-transfected and unstimulated cells. Non-transfected cells underwent an
approximately 20-fold increase in activation following stimulation with TNF-α when
microscopy. Background levels were determined using signals measured in uninfected cells. P-values were obtained
using two-tailed unpaired Student's t-test (*p < 0.05; ** p < 0.01). (D) SpvD inhibits activation of an NF-κB -regulated
promoter. HEK-293 cells were co-transfected with an NF-κB -dependent luciferase reporter plasmid, pTK-Renilla
luciferase and pRK5myc, pRK5myc-SpvC, pRK5myc-SpvD or pRK5myc-SpvDK185A at the indicated amounts (in ng). The
NF-κB pathway was activated with TNF-α and luciferase activity was measured after 8 h. Results are expressed as fold
activation in relation to unstimulated and non-transfected (NT) cells. Values are expressed as mean ± SEM of at least 3
independent experiments and statistical significances were calculated using ANOVA followed by Bonferonni's multiple
comparison test against NT cells (*p < 0.05; ** p < 0.01; *** p < 0.005). (E) Degradation of IκBα is not affected by SpvD.
HEK-293 cells transfected by pRK5myc-SpvD or pRK5myc-YopP were prepared at the indicated times after TNF-α
stimulation and analysed by SDS-PAGE and immunoblotting with anti- IκBα and anti-tubulin antibodies. Ratio of IκBα
normalised to unstimulated cells is indicated below immunoblots.
doi:10.1371/journal.ppat.1005653.g002
SpvD Inhibits Nuclear Transport of p65
PLOS Pathogens | DOI:10.1371/journal.ppat.1005653 May 27, 2016 7 / 26
compared to resting cells. Transfection of 500 ng of empty vector or vector expressing SpvC
did not prevent NF-κB activation, whereas expression of SpvD or SpvDK185A reduced activa-
tion by approximately 65% (Fig 2D). Inhibition of NF-κB activation by SpvD was observed
after transfection of 50 ng of DNA and increased with increasing amounts of DNA. Together,
these results indicate that SpvD is sufficient to block the activation of an NF-κB -regulated pro-
moter and that K185 is not required for SpvD activity.
To investigate if SpvD interferes with IκBα degradation induced upon stimulation with
TNF-α, HEK 293 cells were transfected with plasmids encoding either myc alone (empty vec-
tor), myc-SpvD or myc-YopP (a T3SS effector of Yersinia enterolitica that inhibits IκBα degra-
dation [39–41], used here as a positive control), then stimulated with TNF-α for 5, 10 or 20
min to induce IκBα degradation. Proteins in cell extracts were then analyzed by SDS-PAGE
and immunoblotting. As expected, degradation of IκBα was inhibited in cells expressing myc-
YopP (Fig 2E). However, IκBα was degraded in cells transfected with the empty vector or with
the plasmid encoding myc-SpvD (Fig 2E). Because only approximately 60% of the cell popula-
tion was efficiently transfected (as measured by microscopic examination), a potential effect of
SpvD on IκBα degradation might be difficult to detect when analysing the whole cell popula-
tion by immunoblotting. Therefore, IκBα degradation following TNF-α stimulation was also
analysed by flow cytometry after labelling of the cells with anti- IκBα and anti-myc antibodies.
Levels of IκBα were quantified in myc-positive cells and normalised to non-stimulated cells.
TNF-α -induced IκBα degradation was only prevented in cells expressing YopP (S4F Fig),
indicating that SpvD does not inhibit IκBα degradation and that it must prevent nuclear accu-
mulation of p65 by interfering with the NF-κB pathway after IκBα degradation.
Effect of SpvD on importin-α
Translocation of p65 into the nucleus requires proteins of the karyopherin (KPNA) family
[42,43], also called importin-α. To determine the potential effect of SpvD on KPNA1 and
KPNA3, two importin-α proteins known to interact with p65 [43–45], confocal microscopy
was used to analyse their localisation in HeLa cells. Since attempts to detect endogenous
KPNA1 or KPNA3 using commercial antibodies failed, HeLa cells were co-transfected with
plasmids encoding either KPNA1-FLAG or KPNA3-FLAG and plasmids encoding myc-SpvD
or myc-SpvC (as a control). Cells were immunolabelled with anti-FLAG, anti-myc and anti-
lamin antibodies. Consistent with the localisation of SpvD following its translocation from bac-
teria (S3B Fig), SpvD was found in the host cell cytoplasm after transfection (Fig 3A). In addi-
tion to nuclei containing diffuse labelling of KPNA1-FLAG or KPNA3-FLAG, in some nuclei,
the labelling was predominantly in the region of the nuclear envelope, where it colocalised par-
tially with lamin (Fig 3A). This lamina-associated labelling was observed in all transfected cell
populations, but its frequency was enhanced 2.7-fold by KPNA1 (P<0.001) and 1.6-fold by
KPNA3 (P<0.05) when SpvD was co-expressed (Fig 3B). In addition, the enhanced frequency
of lamina-associated labelling was not observed when SpvC was co-expressed (Fig 3B), indicat-
ing that it is specific to SpvD. To determine if the reorganisation of KPNA1 induced by myc-
SpvD was localised inside or outside the nucleus, differential membrane permeabilisation was
done using either Triton X-100 (under conditions in which it permeabilises both the plasma
and nuclear membranes) or Saponin (at a concentration where it permeabilises only the plasma
membrane). SpvD-induced accumulation of KPNA1 at the nuclear envelope was only observed
when cells were permeabilised with Triton X-100, indicating that this importin accumulates
within the nucleus (Fig 3C).
To analyse the effect of SpvD on importin-α localisation during infection, HeLa cells trans-
fected with plasmids encoding KPNA1-FLAG or KPNA3-FLAG were infected for 14 h with
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Fig 3. SpvD induces an intra-nuclear accumulation of importins. (A) HeLa cells were cotransfected with
FLAG-KPNA1 or FLAG-KPNA3 and pRK5myc-SpvD or pRK5myc-SpvC. Samples were fixed, permeabilised in
Triton X-100, labelled with anti-FLAG (red), anti-myc (blue) and anti-lamin (green) antibodies and analysed by
confocal microscopy. Scale bar, 10 μm.White arrows indicate nuclear lamina-associated KPNAs. (B)
Quantification of cells with nuclear lamina-associated KPNA1 or KPNA3 after transfection with pRK5myc-SpvD or
pRK5myc-SpvC. Values are expressed as mean ± SEM of at least 4 independent experiments (*p < 0.05; ***
p < 0.005). (C) HeLa cells were cotransfected with FLAG-KPNA1 and pRK5myc-SpvD. Samples were fixed,
permeabilised in Triton X-100 or Saponin and labelled as in A. Scale bar, 8 um. (D) HeLa cells were cotransfected
with FLAG-KPNA1 plasmids then infected for 14 h with Salmonella strains. Samples were fixed, permeabilised in
SpvD Inhibits Nuclear Transport of p65
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Salmonella strains. Cells were immunolabelled with anti-Salmonella and anti-FLAG antibodies
and nuclei stained with DRAQ5. Deletion of SpvD led to a significant decrease of the percent-
age of cells with nuclear lamina-associated KPNA1 (Fig 3D and 3E) or KPNA3 (S5 Fig). Cells
infected with the deletion mutant carrying a plasmid-borne wild-type allele of spvD induced a
greater proportion of these structures than the deletion mutant (Fig 3E; p<0.01). These struc-
tures might be an artefact of overexpression of KPNA1 and KPNA3 but do suggest an SpvD-
dependent accumulation of KPNA1 and KPNA3 in the nucleus. To analyse the effect of SpvD
on the localisation of endogenous KPNA1, the amount of endogenous KPNA1 in nuclei of
HeLa cells infected with Salmonella strains was quantified by immunoblotting after cell frac-
tionation. A significant decrease in the amount of endogenous KPNA1 in the nuclei of cells
infected with the ΔspvDmutant was detected, compared to wild-type Salmonella-infected cells
(Fig 3F and 3G). The amount of nuclear KPNA1 was restored to that of the wild-type level in
cells infected with the ΔspvDmutant carrying a plasmid containing spvD (Fig 3F and 3G).
Therefore, in addition to inhibiting nuclear accumulation of p65, SpvD also causes nuclear
accumulation of KPNA1.
SpvD interacts with Xpo2
Recycling of KPNAs from the nucleus to the cytoplasm is mediated by Xpo2 (also named CAS
or CSE1) [46]. To confirm that depletion of Xpo2 inhibits recycling of KPNAs, confocal
microscopy was used to analyse the localisation of KPNA1-FLAG in HeLa cells depleted of
Xpo2 (by siRNA of Xpo2, S6A Fig) and then transfected with a plasmid encoding KPNA1--
FLAG. Cells were immunolabelled with anti-Xpo2 and anti-FLAG antibodies and the percent-
age of cells having detectable cytoplasmic KPNA1 were scored. siRNA of Xpo2 in HeLa cells
caused accumulation of KPNA1 in the nucleus (S6B Fig) and a decrease in the percentage of
cells having detectable KPNA1 in the cytoplasm (S6C Fig), compared to non-treated cells or
cells exposed to a scrambled siRNA. However, the nuclear KPNA1 that was observed in the
absence of Xpo2 was not localised at the lamina, as was observed in the presence of SpvD.
Knock-down of Xpo2 in HeLa cells was reported to cause a decrease of p65 translocation
after stimulation with TNF-α [47]. To determine the effect of inhibition of Xpo2 expression on
p65 localisation in our experiments, confocal microscopy was used to analyse localisation of
p65 in HeLa cells depleted of Xpo-2 and stimulated with TNF-α for 45 min. Cells were immu-
nolabelled with anti-Xpo-2 and anti-p65 antibodies and the intensity of p65 within the nucleus
was quantified using Volocity software. siRNA of Xpo2 in HeLa cells led to a decrease in levels
of nuclear p65 after stimulation with TNF-α compared to control cells (non-treated or scram-
bled siRNA) (S6D and S6E Fig). Since cytoplasmic SpvD and inhibition of Xpo2 expression
both led to nuclear accumulation of KPNA1 and reduced levels of nuclear p65, we hypothe-
sized that SpvD might interact with Xpo2. To investigate this, HEK cells were co-transfected
with a plasmid encoding Xpo2-FLAG and a plasmid encoding either myc-SpvD or myc-SpvC.
Cells were lysed and proteins immunoprecipitated with anti-myc antibody-conjugated beads.
Immunoblot analysis revealed that SpvC failed to interact with Xpo2 but that SpvD and Xpo2
formed a complex (Fig 4A). To determine if SpvD interacts with endogenous Xpo2 in infected
Triton X-100 and labelled with anti-FLAG (red) and anti-Salmonella (blue) antibodies. Cell nuclei were stained with
DRAQ5 (green). Scale bar, 10 μm. (E) Quantification of cells with nuclear lamina-associated KPNA1 after infection
with Salmonella strains. Values are expressed as mean ± SEM of at least 4 independent experiments (** p < 0.01;
*** p < 0.005). (F) HeLa cells were infected for 14 h with Salmonella strains. Nuclear and total cell extracts were
analysed by SDS-PAGE and immunoblotting with anti-KPNA1, anti-histone H3 and anti-GAPDH antibodies. (G)
Ratio of KPNA1 in the nucleus normalised to wild-type -infected cells. Values are expressed as mean ± SEM of 3
independent experiments. P-values were obtained using two-tailed unpaired Student's t-test (*p < 0.05).
doi:10.1371/journal.ppat.1005653.g003
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Fig 4. SpvD interacts with Xpo2 (A) HEK cells transfected with vectors expressing Xpo2-FLAG and myc-
SpvD or myc-SpvC were lysed and proteins were immunoprecipitated with anti-myc antibody-conjugated
beads, or beads as a control. Xpo2-FLAG, myc-SpvD and myc-SpvC were detected in input samples (input)
and after immunoprecipitation (IP) by means of SDS-PAGE and immunoblotting. (B) RAWmacrophages or
(C) HeLa cells were infected for 20 h with wild-type Salmonella expressing either SpvD-2HA, SpvC-2HA or
SseL-2HA. Proteasome inhibitor MG132 was added to the culture medium for the last 2 h of infection. Cells
were then lysed and proteins were immunoprecipitated with HA antibody. SDS-PAGE blots were probed for
HA and endogenous Xpo2, Xpo1 or Xpo5. (D) HeLa cells depleted of Xpo2 (Xpo2 siRNA) or treated with
scramble siRNA (scr. siRNA) and then transfected with FLAG-KPNA1 and myc-SpvD were fixed and labelled
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cells, RAWmacrophages and HeLa cells were infected with Salmonella expressing either
SpvD-HA or two other effectors translocated by the SPI-2 T3SS (SpvC-HA or SseL-HA), fol-
lowed by immunoprecipitation using anti-HA conjugated beads. Input and output samples
were analysed by SDS-PAGE and immunoblotting with anti-Xpo2 and anti-HA antibodies.
SpvD bound to endogenous Xpo2 following its translocation from intracellular bacteria (Fig
4B and 4C). No binding was observed when cells were infected with Salmonella expressing
SpvC-2HA or SseL-2HA despite the fact that these two effectors were evidently more abundant
than SpvD-2HA (Fig 4B and 4C). Xpo1 and Xpo5 are additional members of the exportin fam-
ily, have some structural similarities to Xpo2 and mediate the export of proteins with a nuclear
export signal and of RNA respectively [48]. However, when membranes were probed with
anti-Xpo1 and anti-Xpo5 antibodies, no interaction between SpvD-2HA and these proteins
was detected (Fig 4C). To analyse if the interaction of Xpo2 with SpvD affects the cellular loca-
lisation of Xpo2, the amount of Xpo2 in total cell lysates and in cytoplasm of HeLa cells
infected with Salmonella strains was quantified by immunoblotting after cell fractionation. No
cytoplasmic increase of Xpo2 in wild-type -infected cells was detected (S7A Fig). In addition,
HeLa cells were transfected with plasmids encoding myc-SpvD or myc-SpvC (as control) and
the amount of Xpo2 in total cells lysates and in cytoplasm was quantified by immunoblotting
after cell fractionation (S7B Fig). No cytoplasmic increase of Xpo2 in cells transfected with
plasmid encoding myc-SpvD was detected, suggesting that SpvD does not sequester Xpo2 in
the cytoplasm.
These results show that SpvD localises to the host cell cytoplasm, inhibits nuclear accumula-
tion of p65, causes nuclear accumulation of KPNA1 and KPNA3, and binds specifically to
Xpo2. To determine if nuclear lamina-associated KPNA1 induced by SpvD is dependent on
Xpo2, confocal microscopy was used to analyse the localisation of KPNA1-FLAG in HeLa cells
depleted of Xpo2 and then transfected with a plasmid encoding KPNA1-FLAG with or without
a second plasmid encoding myc-SpvD. Cells were immunolabelled with anti-FLAG and anti-
myc antibodies and the number of cells with nuclear lamina-associated KPNA1-FLAG were
counted (Fig 4D). When SpvD was present, the frequency of lamina-associated KPNA1 was
significantly enhanced by 2.1-fold in non-treated HeLa cells and by 2.0-fold in cells exposed to
a scrambled siRNA. However, no statistical difference was observed in HeLa cells depleted of
Xpo2. Together, these results indicate that the ability of SpvD to induce lamina-associated
KPNA1 is dependent on the presence of Xpo2.
Effect of SpvD on virulence and cytokine expression in mice
Previous work failed to reveal a clear and consistent role of SpvD in virulence in vivo [27–30].
To reassess the possibility of an effect of SpvD on systemic growth of bacteria, mice were inocu-
lated by intraperitoneal injection of a mixture of equivalent cfu of kanamycin resistant wild-
type bacteria and the ΔspvDmutant strain. After 72 h of infection, bacteria were quantified
after plating spleen homogenates on LB medium and LB medium containing kanamycin to dis-
tinguish the strains. The competitive index (CI) for the ΔspvDmutant was 0.48 ± 0.11
(P0.05) when compared to wild-type (Fig 5A). To verify that this attenuation was due to loss
of SpvD, a second experiment was conducted in which mice were infected as above but with a
mixture of ΔspvDmutant and the same strain carrying spvD allele on the pACYC plasmid. The
CI for this combination was 0.47 ± 0.11 (P0.005) (Fig 5A), showing that the spvD allele
with anti-myc and anti-FLAG antibodies. Intra-nuclear rings of KPNA1 were quantified blindly by microscopy.
Values are expressed as mean ± SEM of 3 independent experiments and P-values were obtained using two-
tailed unpaired Student's t-test (*p < 0.05; ** p < 0.01).
doi:10.1371/journal.ppat.1005653.g004
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Fig 5. Effect of SpvD on virulence and cytokine expression in vivo. (A) Lack of SpvD causes virulence
attenuation of Salmonella in the mouse model of systemic infection. C57BL/6 mice were inoculated by
intraperitoneal injection (i.p.) with equal numbers (2.5 x 104 CFU) of indicated bacteria. Bacteria were
recovered from infected spleens 3 days post-inoculation. CI values were calculated as described in materials
and methods. The scatter plot displays values obtained for individual mice and the mean is indicated (line)
(*p < 0.05; *** p < 0.005). (B-D) C57BL/6 mice were inoculated by i.p. with indicated bacteria, RNAs from
splenic macrophages were recovered at 2 days post-inoculation and serpinB2 (B), tnf-α (C) and il1-β (D)
mRNA levels were analysed by qRT-PCR. The transcript levels were normalized to the levels of rsp9, which
were constant under all conditions used, and then expressed relative to those of wild-type-infected mice.
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rescues the growth defect of the mutant, thereby confirming that SpvD contributes to systemic
virulence in the mice.
To assess the effect of SpvD on LPS-induced genes in mice, RNA levels of serpinB2, tnf-α and
il1-β in infected splenic macrophages of C57BL/6 mice inoculated with Salmonella strains were
compared by qRT-PCR (Fig 5B–5D). For serpinB2mRNA transcripts, no significant differences
were detected betweenmice infected with different Salmonella strains (Fig 5B). No significant dif-
ferences in tnf-α and il1-β were detected between mice infected with the wild-type or ΔspvD
mutant bacteria, but macrophages infected with ΔspvD, pspvD bacteria contained fewer tnf-α and
il1-β transcripts (Fig 5C and 5D), indicating that SpvD can depress cytokine expression in vivo.
Discussion
As a basis for identifying SPI-2 T3SS effectors that interfere with host proinflammatory
immune signalling, we analysed the effect of the SPI-2 T3SS on mRNA levels of tnf-α and il1-β
in wild-type BMM at 10 h post-bacterial uptake. No obvious differences were detected, suggest-
ing that either SPI-2 effectors do not have a significant effect on macrophage mRNA levels or
that their activities are masked by the massive changes induced by LPS [23] and possibly other
PAMPs. Use of TLR4-/- BMMs provided evidence that the SPI-2 T3SS does suppress pro-
inflammatory cytokine production. Among several SPI-2 T3SS effector mutants that were
tested subsequently, infection with either ΔspvC or ΔspvD strains led to increased tnf-α and il1-
β secretion. SpvD and SpvC-dependent effects also occurred in HeLa cells, showing that their
functions are not confined to macrophages. The effect of the ΔspvCmutant was unsurprising,
since two previous studies have indicated an anti-inflammatory effect of SpvC, caused by its
phosphothreonine lyase activity on ERK1/2, p38 and JNK [14,49].
SpvD was identified in a proteomic study as being secreted by both the SPI-1 and SPI-2
T3SSs and its translocation into J774 macrophage-like cells was confirmed using a CyaA fusion
protein assay [29]. Using an epitope-tagged version under the control of its own promoter in
the virulence plasmid, we showed that SpvD is secreted into the culture medium in a SPI-2
T3SS-dependent manner. SPI-2 T3SS-dependent translocation of SpvD into the cytoplasm of
infected cells was also confirmed by immunofluorescence microscopy, but only when cells had
been treated with a proteasome inhibitor. In addition, bacterially translocated SpvD-2HA was
barely detectable in the input sample from infected HeLa cells and RAWmacrophages,
whereas SpvC-2HA and SseL-2HA were clearly more abundant (Fig 4B and 4C). This indi-
cates that SpvD is translocated in relatively small amounts and/or is more prone to degradation
compared to other effectors. Despite some amino acid similarity in a region containing the cat-
alytic lysine of SpvC, SpvD did not require the corresponding lysine to suppress TNF-depen-
dent activation of an NF-κB reporter. Furthermore, following transfection, SpvC but not SpvD
inhibited activation of an AP-1-dependent promoter, showing that these effectors are likely to
have distinct biochemical activities and physiological effects.
Several other bacterial effectors have been shown to interfere with NF-κB signalling. In
most cases they affect the degradation of IκBα and/or the release of p65 [4–6]. For example,
the Shigella flexneri kinase OspG interacts with host ubiquitin-conjugating enzymes to abro-
gate IκBα degradation and thus blocks nuclear translocation of p65 [50]. NleC of enteropatho-
genic and enterohaemorrahgic E. coli is a metalloprotease that degrades both free cytosolic p65
Results are expressed as mean ± SEM of at least 3 independent experiments. P-values were obtained using
two-tailed unpaired Student's t-test (*p < 0.05). (E) Model depicting pathways targeted by SpvC and SpvD to
overcome PAMP-induced defences in host cells. Immunoblots are representative of three independent
experiments.
doi:10.1371/journal.ppat.1005653.g005
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and p65 when complexed with IκBα [33–35]. Abrogation of p65 translocation has also been
described for the effectors NleB and NleE from enteropathogenic E. coli and OspZ from Shi-
gella flexneri [51,52] NleE is an unusual methyltransferase that modifies crucial cysteines in the
zinc finger domains in ubiquitin-chain sensory proteins TAB2 and TAB3 and thereby disrupts
NF-κB signalling [53]. NleB is a N-acetylglucosamine transferase whose action blocks signal-
ling from the TNFR and its associated adapters [54–56]. We found that SpvD prevents nuclear
accumulation of p65 by interfering with the NF-κB pathway after IκBα degradation but it did
not affect overall cellular levels of p65. SpvD might not be the only effector that inhibits the
nuclear translocation of p65 following IκBα degradation. Indeed, the Bordetella effector BopN
[57] localises to the nucleus and appears blocks nuclear translocation of p65 without affecting
IκBα degradation; however, its host target(s) remain to be identified. SpvD might specifically
target the import of NF-κB -associated proteins as it also prevents nuclear accumulation of
NF-κB subunit p50 but not of STAT2.
There are 7 different importin-α (KPNA) isoforms and several have the capacity to interact
with p65. Fagerlund et al. reported an interaction between p65 and both KPNA4 (α3) and
KPNA3 (α4) but not KPNA2 (α1) [43,44], while Cunningham et al. showed that p65 binds to
KPNA2 [42], Liang et al. reported that nuclear translocation of p65 relies mainly on KPNA2 [47]
and Sun et al. showed that p65 translocation in leucocytes does not involve KPNA4, but rather
KPNA1 (α5) [45]. p65 might use different isoforms depending on host cell type, time and
strength of pathway activation and other conditions. Furthermore, in vitro binding assays with
purified proteins or lysates might not reflect normal physiological interactions. However, our
results showing that SpvD affects nuclear accumulation of both p65 and p50 are consistent with
its effect on KPNA4 (α3), which mediates nuclear import of both transcription factors [43].
We were unable to distinguish endogenous KPNAs by confocal microscopy using commer-
cial antibodies and therefore cells were transfected with plasmids encoding FLAG-tagged
KPNAs and anti-FLAG antibodies were used to detect them by confocal microscopy. Following
transfection or bacterial translocation, SpvD stimulated a nuclear lamina-associated accumula-
tion of overexpressed KPNA1 and KPNA3. No effect was observed on KPNA2 or KPNA4 loca-
lisation. We are unaware of other bacterial proteins that cause a similar effect, but Hantaan
virus nucleocapsid protein N inhibits p65 nuclear translocation by binding directly to KPNAs
[58]. We were unable to obtain evidence for an interaction between SpvD and KPNA1, 2, 3 or
4 by co-immunoprecipitation assays. Instead, following transfection or bacterial translocation,
SpvD interacted specifically with endogenous Xpo2, which is required for recycling of KPNAs
from the nucleus to the cytoplasm [46]. Inhibition of Xpo2 expression led to nuclear accumula-
tion of KPNA1 and also reduced nuclear translocation of p65 ([47] and this work). Despite
apparently stable binding between SpvD and Xpo2, Xpo2 localisation was not noticeably
affected by SpvD. It is possible that SpvD is an enzyme that modifies Xpo2. However, following
immunoprecipitation by SpvD-2HA after infection of macrophages, mass spectrometric analy-
sis of Xpo2 did not reveal any post-translational modifications such as phosphorylation, acety-
lation or conjugation by ubiquitin and ubiquitin-like proteins. It is possible that such
modifications did occur but are relatively transient, labile or did not survive the extraction or
ionization processes. Alternatively SpvD might affect Xpo2 function non-enzymatically, or use
Xpo2 as a docking site or cofactor to mediate an effect on another component of the importin/
exportin machinery. A link between binding of SpvD to Xpo2 and the effect of SpvD on
KPNA1 was established by showing that the SpvD-induced accumulation of KPNA1 at the
nuclear lamina was dependent on Xpo2. Sequestration of KPNA in the nuclear envelope has
been observed in cells treated with histone deacetyltransferase inhibitors [59]. However, this
treatment also resulted in accumulation of Xpo2 in nuclear aggregates [59], which are clearly
distinct from the effects of SpvD.
SpvD Inhibits Nuclear Transport of p65
PLOS Pathogens | DOI:10.1371/journal.ppat.1005653 May 27, 2016 15 / 26
Due to the lack of clear and consistent data on the contribution of SpvD to Salmonella viru-
lence [27–30], we reassessed its effect on systemic growth of bacteria in mice. Our evidence
indicates that SpvD does contribute to systemic virulence in the mouse. The disparity might be
attributable to the different mouse strains used in each study. We did not detect a significant
difference in the levels of tnf-α and il1-βmRNA in splenic macrophages of wild-type mice
infected with the wild-type or spvDmutant strains. However, the complemented mutant in
which SpvD was produced from a plasmid caused a significant reduction of tnf-α and il1-β
mRNA levels in splenic macrophages of wild-type mice. It seems likely that the effects of SpvD
produced by wild-type bacteria are subtle and can be masked by other immune-modulating
bacterial molecules present in these relatively short-term infection assays, as evidenced by the
initial experiments using wild-type macrophages.
Together, our evidence suggests that an interaction between SpvD and Xpo2 disrupts the
nuclear/cytoplasm cycling of KPNA1 and KPNA3, which interferes with nuclear translocation of
p65 and activation of NF-κB regulated promoters (Fig 5E). Whatever the precise mechanism, it
is remarkable that Salmonella has evolved the means to inhibit the two main pro-inflammatory
signalling pathways that are activated following detection of bacterial pathogens through two
proteins (SpvC and SpvD) that are encoded by adjacent genes on the same operon (Fig 5E).
Materials and Methods
Bacterial strains and plasmids
The S. Typhimurium strains (wild-type 12023 and its mutant derivatives) and plasmids used in
this study are listed in S2 Table. Primers used for construction of all strains or plasmids are
listed in S3 Table. Bacteria were grown in Luria Bertani (LB) medium at 37°C with shaking
and supplemented with ampicillin (50 μg/ml), kanamycin (50 μg/ml) or chloramphenicol
(34 μg/ml) as appropriate. S. Typhimurium mutant strains were constructed using a one-step λ
Red recombinase chromosomal inactivation system [60]. Plasmid pKD4 was used as the tem-
plate to amplify the kanamycin (km) resistance gene and amplification reaction products were
transferred into pKD46-containing bacteria expressing λ Red recombinase by electroporation.
To excise the km resistance marker, the mutant strains were transformed with pCP20 helper
plasmid expressing the FLP recombinase. Virulence plasmid-encoded spvD was double hemag-
glutinin (HA)-tagged using the procedure described previously [61]. To obtain pACYCspvD-
2HA, the double-HA tagged spvD was amplified from the virulence plasmid by PCR and
cloned into pACYC184. To obtain pRK5-myc-SpvD, pRK5-myc-SpvC, pRK5-myc-YopP and
pRK5-myc-NleC, the genes of interest were amplified by PCR and cloned into pRK5-myc. To
obtain pRK5-myc-SpvDK185A, site-directed mutagenesis was performed by inverse PCR using
pRK5-myc-SpvD as DNA template. Lysine at residue 185 of SpvD was changed to Alanine
using SpvDK185A1 and SpvDK185A2. To create pcDNA3.1Xpo2-FLAG, the pCDNA3.1Xpo5-
FLAG construct [62] was digested by NheI and XhoI restriction enzymes to obtain pcDNA3.1
vector backbone. In parallel, total cellular RNA was extracted from HeLa cells using the Qiagen
RNeasy mini kit following manufacturer’s instructions. RNA were reverse transcribed to
cDNA using the SuperScript II Reverse Transcriptase kit (Invitrogen) and Xpo2, encoded by
the gene CSE1L, was amplified with the Expand Long Template PCR system (Roche) from
total cDNA using primers CAS NheI and CAS XhoI and cloned into pcDNA3.1. Obtained plas-
mids were verified by sequencing.
Antibodies
The following antibodies were used for immunofluorescence, FACS and immunoblot analysis:
goat anti-Salmonella (CSA-1, Kirkegaard and Perry Laboratories), rabbit anti-DnaK [63], rat
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anti-HA (3F10, Roche), mouse anti-HA (HA11, Covance), mouse anti-FLAG (M2, Sigma-
aldrich), rabbit anti-myc (Cell Signaling), mouse anti-β tubulin (Sigma-aldrich), rabbit poly-
clonal anti-GAPDH (Abcam), rabbit or goat anti-p65 (Santa Cruz), mouse anti- IκBα (Cell
Signaling), rabbit polyclonal anti-lamin B1 (Abcam), rabbit polyclonal anti-Xpo2 (CSE1L,
Abcam), rabbit anti-Xpo1 (CRM1, Santa Cruz), rabbit anti-Xpo5 (Sigma-aldrich), rabbit anti-
histone H3 (Abcam), rabbit anti-KPNA1 (Proteintech), mouse anti-p50 (Biolegend) and rabbit
anti-STAT2 (Santa Cruz). Alexa Fluor 488-, 555- and 633- conjugated donkey anti-rat, anti-
mouse, anti-goat and anti-rabbit antibodies were from Life technologies, UK.
pH shift and protein secretion assay
Protein secretion assays were done as described previously [31]. Briefly, bacterial strains were
grown overnight in LB broth and sub-cultured in MgM-MES medium pH 5.0 for 4 h to assem-
ble and activate SPI-2 T3SS. Bacterial cells were then collected by centrifugation, re-suspended
into MgM-MES at pH 7.2 and incubated at 37°C for 1.5 h.
Cell culture
HeLa (human epithelial cell line) cells, HEK (human embryonic kidney) cells and RAW264.7
macrophages used in this study were obtained from the European Collection of Animal and
Cell Cultures (Salisbury, UK) and maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Life technologies) supplemented with 10% foetal calf serum (FCS) (PAA Laborato-
ries or Sigma-Aldrich) at 37°C in 5% CO2. Primary bone-marrow macrophages (BMM) were
obtained from C57BL/6 wild-type (Charles River) or TLR4-/- mice (kind gift from Prof Maria
Belvisi and Dr Mark Birrell (Respiratory Pharmacology, National Heart and Lung Institute,
Imperial College, London)). BMM were grown in RPMI (Life Technologies) supplemented
with 10% FCS, 2 mM glutamine, 1 mM sodium pyruvate, 10 mMHEPES, 50 μM β-mercap-
toethanol, 100 U/ml penicillin/streptomycin (Sigma-Aldrich), and L929 cell-conditioned
medium 20% (vol/vol; National Institute for Medical Research). After 3 days of culture, further
fresh complete medium containing L929-cell conditioned medium was added to the growing
macrophages. On day 7, cells were washed and seeded in complete medium without antibiotic
and incubated for 24 h before bacterial challenge.
DNA transfection
HeLa cells were seeded in 24-well plates at a concentration of 2 x 104 cells/well 24 h before
transfection with Lipofectamine 2000 (Life technologies) following the manufacturer’s proto-
col. Unless indicated, 100 ng of DNA were used. Cells were used 24 h after transfection.
siRNA transfection
The siRNA oligo duplex targeted against Xpo2 was custom synthesized using a previously
described targeting sequence [64] (ThermoScientific). The scramble control oligos (Thermo-
Scientific) were designed not to target any human mRNA transcript.
HeLa cells were seeded in 24-well plates at a concentration of 5 x 104 cells/well and grown
until they were 70% confluent. siRNA transfection using RNAiMAX (Life technologies) was
carried out according to the manufacturer’s protocol with a final concentration of siRNA oligos
of 10 nM. A scramble oligo sequence was included in all experiments as a negative control.
Cells were used 72 h after siRNA transfection.
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Bacterial infection of cells
HeLa cells and RAW264.7 macrophages were infected with S. Typhimurium strains as
described previously [65]. BMM were infected as described previously [66].
TNF-α stimulation
HeLa cells were seeded into 24-well plates at a concentration of 2 x 104 cells/well 24 h before
stimulation. Unless indicated, cells were stimulated with TNF-α (10 ng/mL) for 45 min at
37°C. For IκBα degradation analysis, at indicated times after TNF-α stimulation, cells were
washed and either lysed for immunoblotting analysis or trypsinised for flow cytometry assays.
Fixation, permeabilisation, fluorescence labelling and microscopy
All samples were fixed in 3% paraformaldehyde (PFA) and unless indicated, permeabilised in
0.2% Triton-X100 for 6 min. All antibodies were diluted to the appropriate concentrations in
PBS containing 10% horse serum. The coverslips were washed twice in PBS, incubated with
primary antibodies for 1 h, washed 3 times in PBS, incubated with secondary antibodies for 30
min and stained with the nucleic acid dye, DRAQ5 (Alexis) for 20 min. For specific plasma
membrane permeabilisation, all antibodies were diluted in PBS containing 10% horse serum
and 0.1% saponin (Fisher) and after fixation with PFA, cells were washed twice in PBS, incu-
bated with primary antibodies for 1 h, washed 3 times in PBS and incubated with secondary
antibodies for 30 min. Coverslips were washed and mounted onto glass slides using Mowiol
mounting medium. Cells were analysed using either an epi-fluorescence microscope (BX50;
Olympus) or a confocal laser-scanning microscope (LSM510 or LSM710; Zeiss GmBH). All
scorings were done blindly and at least 100 cells were analysed per coverslip. To determine p65
intensity in the nucleus, confocal three-dimensional Z-stacks were acquired for each sample
using a 63x objective with a slice of increment of 0.5 μm. At least 50 infected cells were imaged
for each condition. Rendered three-dimensional stacks were analysed with Volocity image
analysis software (Perkin Elmer).
Cell lysis, cell fractionation and immunoblotting
HeLa cells were collected from a well in a 24-well plate 3 days after transfection with siRNAs.
Infected BMM were collected from a well in a 24-well plate at 10 h post-bacterial uptake. For
IκBα degradation analysis, at indicated times after TNF-α stimulation, cells were washed and
collected after trypsinisation. Cells were lysed in 5x sample buffer (0.25 M Tris-Cl pH 6.8, 10%
SDS, 10% β-Mercaptoethanol, 10% glycerol, 0.05% Bromophenol Blue). Samples were boiled
for 5 min and separated by SDS-PAGE. Samples were then transferred onto PVDF Immobi-
lon-P membranes (Millipore), and Immunoblotting was carried out according to the manufac-
turer’s instructions. Immunoblots shown in each figure are representative of three independent
experiments.
For cell fractionation, 5 x 106 cells were collected, washed twice with cold PBS and lysed in
cold hypotonic buffer (10 mMHEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1
mMDTT) supplemented with complete protease inhibitor cocktail without EDTA (Roche) on
ice for 15 min. NP-40 was added to a final concentration of 0.625% and cells were vortexed vig-
orously for 10 s. Samples were centrifuged for 30 s at 16000 g and the supernatants were har-
vested as cytoplasmic fraction. The nuclear pellets were then resuspended in cold hypertonic
buffer (20 mMHEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT) supple-
mented with complete protease inhibitor cocktail (Roche). The samples were incubated at 4°C
for 15 min with agitation. The supernatants were collected after centrifugation for 5 min at
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16000 g as nuclear proteins. Cytoplasmic and nuclear proteins were frozen in 5x sample buffer
at -20°C until use.
Flow cytometry quantification of cellular protein levels
For flow cytometry assays to determine protein levels by immunolabelling, trypsinised cells
were washed twice in PBS prior to fixation in 3% PFA for 20 min at room temperature. Cells
were then washed twice in PBS and permeabilised in 0.08% Triton X-100 for 10 min. Cells
were incubated for 1 h at room temperature with primary antibodies diluted in PBS. Cells were
then washed twice and incubated for 30 min with secondary antibodies diluted in PBS. Finally,
cells were washed and resuspended in PBS. Flow cytometry was performed on a two-laser, four
colour FACSCalibur cytometer (BD Biosciences) using Cell Quest Pro software. For each sam-
ple, 45,000–50,000 events were analysed. Collected data were analysed with FlowJo 8.1.1 soft-
ware (Treestar).
RNA extraction, microarray analysis and qRT-PCR
Cells subjected to LPS (1 μg/ml) stimulation for 2 h were used as controls. At 10 h post-uptake,
BMM were washed and RNA was isolated using TRIzol according to the manufacturer’s direc-
tions (Invitrogen). Contaminating genomic DNA was removed using DNaseI (Qiagen). RNAs
(400 ng) were reverse transcribed with Quantiscript Reverse transcriptase (QuantiTect Reverse
Transcription kit, Qiagen) for 25 min at 42°C. Quantification of the mRNA levels was done
using SensiMix dT kit (Quantace) and specific primers (S3 Table) on Rotor-Gene 3000 (Cor-
bett Research).
Enzyme-linked immunosorbent assay
For TNF-α and IL1-β quantification, at 10 h or 24 h post-bacterial uptake or after 2 h of LPS
(1 μg/ml) stimulation, supernatants from infected BMM were collected, centrifuged and stored
at −80°C. For IL-8 quantification, at 8 h, 12 h or 24 h post-bacterial uptake, supernatants from
infected HeLa cells were collected, centrifuged and stored at −80°C. The amount of TNF-α,
IL1-β or IL-8 released in the culture supernatant was determined by enzyme-linked immuno-
sorbent assay (ELISA; R&D Systems) and cytokine concentrations were assessed according to
the manufacturer's instructions.
Luciferase reporter assays
HEK293 cells were seeded at a density of 5 x 104 cells per well in a 24-well plate 16 h prior to
transfection. Cells were transfected for 16 h with 50 ng of luciferase reporter plasmid (AP-1 or
NF-κB dependent luciferase reporter plasmid), 30 ng of pTK-Renilla luciferase, and 100 ng of
expression vectors (myc-effector or myc vector alone). For MAPK reporter assays, cells were
then incubated with 25 ng/ml of PMA for 6 h and harvested in 100 μl of passive lysis buffer
(Promega). For NF-κB reporter assays, cells were then incubated with 10 ng/ml of TNF-α for 8
h and harvested in 100 μl of passive lysis buffer (Promega). Luciferase activity was measured
using Dual Luciferase reporter assay system (Promega) and a TD20/20 Luminometer (Turner
Designs) and normalised according to Renilla luciferase intensity. The data presented are from
at least three independent experiments.
Immunoprecipitation
HEK cells were seeded at a density of 2 x 105 cells per well in a 6-well plate 16 h prior to trans-
fection. Cells were transfected with 1 μg of indicated DNA with Lipofectamine 2000. Three
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wells were used per condition. Cells were lysed 24 h post-transfection in GTPase lysis buffer
(50 mM Tris Cl pH 7.4, 150 mMNaCl, 5 mMMgCl2, 0.5% Triton X-100) supplemented with
complete protease inhibitor cocktail without EDTA (Roche) on ice for 30 min. Lysates were
then centrifuged at 16000 g and the supernatants were harvested and incubated with 25 μl of
anti-myc conjugated beads for 2 h at 4°C. Samples were then centrifuged at 1500 g and super-
natant was removed. Pellets were washed 3 times with 50 mM Tris Cl pH 7.4. Samples were
then separated by SDS-PAGE and analysed by immunoblot.
HeLa cells and RAWmacrophages were grown on 150 mm dishes (Corning) seeded at a
concentration of 4x106 cells and 8x106 per dish, respectively. Two dishes were used per condi-
tion. Cells were then infected with S. Typhimurium strains expressing either SpvD-2HA,
SpvC-2HA or SseL-2HA for 18 h. Proteasome inhibitor MG132 (10 μg/ml) was added to the
culture medium for 2 h prior to cell lysis. Cells were lysed in GTPase lysis buffer supplemented
with complete protease inhibitor cocktail without EDTA (Roche) on ice for 30 min. Lysates
were then centrifuged at 16000 g and the supernatants were harvested and incubated with 25 μl
of anti-HA beads (Pierce) for 2 h at 4°C. Samples were then placed on a magnetic rack and
supernatant was removed. Pellets were washed 3 times with 5 mM Tris Cl pH 7.4, 15 mM
NaCl, 0.5 mMMgCl2, 0.05% Triton X-100. Proteins bound to anti-HA beads were eluted using
HA-peptide (Sigma-Aldrich) and were then separated by SDS-PAGE and analysed by
immunoblotting.
Mice infections
To prepare the inocula, bacteria were first grown overnight in LB broth and then subcultured
at a dilution of 1:100 for a further 2 h. Cultures were diluted to a concentration of 2.5 × 104 cfu/
ml in physiological saline.
For competitive index (CI) measurements, bacterial cultures were mixed for intra-peritoneal
inoculation (0.2 mL per mouse). Viable bacteria in inocula were quantified by dilution and
plating onto LB agar plates with appropriate antibiotics to distinguish between strains. Female
C57BL/6 mice (Charles River, 6–12 weeks) were sacrificed at 3 days post inoculation. The
spleens were removed aseptically and homogenized in distilled water by mechanical disruption.
Serial dilutions were plated on LB agar for cfu enumeration. Strains were distinguished by dif-
ferential counting or replica plating on antibiotic-supplemented plates. For each mouse, the CI
was calculated by dividing the output ratio (i.e. strain a versus strain b) divided by the input
ratio. The log CI values were used to calculate means and for statistical analyses. A wild-type
strain carrying a kanamycin resistance cassette on the chromosome (STM0857, [14]) was used
to represent wild-type bacteria in the CI assay. Its CI was 0.97 ± 0.18 (Fig 5A) when compared
to wild-type bacteria, indicating that kanamycin resistance cassette does not affect virulence.
For mRNA extraction, mice were infected by intra-peritoneal inoculation with 1 × 104 bac-
teria and sacrificed 48 h post-inoculation. Spleens were harvested, homogenized and splenic
CD11b(+) cells enriched using magnetic beads following manufacturer’s instructions (Milte-
neyi Biotec). RNA of purified cells was isolated using TRIzol according to the manufacturer’s
directions (Invitrogen). mRNA reverse transcription and qRT-PCR were done as described
above.
Ethics statement
Animals were used in accordance with UK Home Office regulations. The Imperial College Ani-
mal Welfare and Ethical Review Body (AWERB) committee approved the project licence for
animal research (70/7768). The following people formed the panel: Applicant Scientist, CBS
site manager / NACWO, NVS, Peer Scientist and a Lay person.
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Statistical analysis
All results are reported as mean ± Standard Error of the Mean (SEM). Statistical analyses were
done using two-tailed unpaired Student’s t-test or ANOVA followed by Bonferonni's multiple
comparison test. Differences denoted in the text as significant fall below a p-value of 0.05.
Supporting Information
S1 Fig. The SPI-2 T3SS does not affect mRNA levels of all the LPS-responsive genes.Wild-
type and TLR4-/- BMMs were non-infected (NI), exposed to LPS (100 ng/ml) or infected with
wild-type or ΔssaV strains for 10 h and mRNA levels of serpinB2 were analysed by qRT-PCR
after reverse transcription of RNA extracted from cells. The transcript levels were normalized
to the levels of rsp9, which were constant under all conditions used, and then expressed relative
to those of non-infected wild-type BMMs. Results are expressed as mean ± SEM of at least 3
independent experiments.
(TIF)
S2 Fig. SpvD and SpvC reduce pro-inflammatory cytokine secretion in HeLa cells. Levels of
secreted IL-8 at 8 h, 12 h or 24 h post-uptake were quantified by ELISA in supernatants of
HeLa cells, infected with indicated strains of S. Typhimurium. The cytokine levels were
expressed relative to those of HeLa cells infected with wild-type bacteria. Results are expressed
as means ± SEM of 3 independent experiments and P-values were obtained using two-tailed
unpaired Student's t-test. (p< 0.05;  p< 0.01;  p<0.005).
(TIF)
S3 Fig. SpvD-2HA is secreted and translocated into infected macrophages in SPI-2 T3SS-
dependent manner. (A) Secretion of SpvD-2HA upon pH shift. Strains producing double-HA
tagged SpvD from the virulence plasmid were used for pH shift analysis (as described in mate-
rials and methods). Secreted fractions and whole cell lysates were subjected to SDS-PAGE and
immunoblotting. The intrabacterial protein DnaK was used as control. (B) RAWmacrophages
were infected for 24 h with Salmonella strains producing SpvD-2HA from the pSLT virulence
plasmid; 10 μg/ml of MG132 was added to the culture media for the last 2 h of infection. Sam-
ples were fixed and labelled with antibodies against Salmonella and SpvD-2HA (green and red,
respectively, on merged images). Scale bar, 2 μm.
(TIF)
S4 Fig. SpvD does not affect cellular p65 levels and acts downstream of IκBα. (A) TLR4-/-
BMMs were infected with different strains of Salmonella as indicated and p65 levels assessed
by immunoblotting at 10 h post uptake. The same membrane was probed for GADPH as a
loading control. Ratio of p65 normalised to wild-type-infected cells is indicated below immu-
noblots. (B) HeLa cells were infected for 14 h with Salmonella strains. Nuclear and total cell
extracts were analysed by SDS-PAGE and immunoblotting with anti-histone H3, anti-
GAPDH, anti-p65, anti-p50 and anti-STAT2 antibodies. Ratio of p65, p50 and STAT2 normal-
ised to wild-type-infected cells are indicated below immunoblots. (C) Representative flow
cytometry histogram of levels of p65 in HeLa cells non transfected (red) or transfected by
pRK5myc-SpvD (blue), pRK5myc-SpvC (brown) or pRK5myc-NleC (green). (D) Quantifica-
tion of p65 in cells expressing SpvD, SpvC or NleC. Data were normalised to non-transfected
control cells (NT). Results are expressed as means ± SEM of 3 independent experiments and P-
values were obtained using two-tailed unpaired Student's t-test. ( p< 0.01, compared to NT).
(E) Alignment of SpvD C-terminal sequence (amino acids 181 to 213) with known bacterial
effectors with phosphothreonine lyase activity: OspF (Shigella flexneri), VirA
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(Chromobacterium violaceum), HopAI1 and HopAI1bis (Pseudomonas syringae) and SpvC (S.
Typhimurium). The catalytic lysine residue of known phosphothreonine lyase proteins is indi-
cated in the box. (F) HEK-293 cells transfected by pRK5myc-SpvD or pRK5myc-YopP were
prepared at the indicated times after TNF-α stimulation and analysed by FACS using anti-myc
and anti-IκBα antibodies. Results are normalised to unstimulated cells, values are expressed as
mean ± SEM of at least 3 independent experiments and compared to pRK5-myc (p< 0.05; 
p< 0.01).
(TIF)
S5 Fig. SpvD induces intra-nuclear accumulation of KPNA3 during infection.HeLa cells
were cotransfected with FLAG-KPNA3 plasmids then infected for 14 h with Salmonella strains.
Quantification of cells with nuclear lamina-associated KPNA3 after infection with Salmonella
strains was assessed by microscopy. Values are expressed as mean ± SEM of at least 4 indepen-
dent experiments ( p< 0.01;  p< 0.005).
(TIF)
S6 Fig. Xpo2 is required for importin recycling and p65 nuclear translocation. (A) Total
HeLa cell levels of Xpo2 were analysed by immunoblotting in control cells or cells treated with
oligo for Xpo2. Intracellular levels of GAPDH were used as a loading control. (B) HeLa cells
depleted of Xpo2 (Xpo2 siRNA) or treated with scramble siRNA (scr. siRNA) and then trans-
fected with FLAG-KPNA1 were fixed, labelled with anti-Xpo2 (blue), anti-FLAG (green). Cell
nuclei were stained with DRAQ5 (red). Scale bar, 8 μm. (C) Localisation of KPNA1 in control
cells (ctrl) or Xpo2 depleted (Xpo2 siRNA) was analysed by quantitative confocal immunofluo-
rescence microscopy. Results are expressed as means ± SEM of 3 independent experiments and
P-values were obtained using two-tailed unpaired Student's t-test ( p< 0.005). (D) Repre-
sentative immunofluorescence fields of p65 localisation using anti-p65 (red) in control cells or
depleted of Xpo-2 (siRNA) after TNF-α stimulation (10 ng/ml) for 45 min. Cell nuclei were
stained with DRAQ5 (green). Scale bar, 5 μm. (E) Quantification of p65 intensity in the nucleus
was analysed by 3D confocal microscopy in cells with and without TNF-α treatment. Data
were normalised to unstimulated cells in each condition (control and siRNA) and p65 nuclear
translocation was expressed as the ratio of p65 intensity in the nucleus after stimulation com-
pared to unstimulated cells. Results are expressed as means ± SEM of 3 independent experi-
ments and P-values were obtained using two-tailed unpaired Student's t-test ( p< 0.05).
(TIF)
S7 Fig. Cellular localisation of Xpo2 is not altered by SpvD. (A) HeLa cells were infected for
14 h with Salmonella strains. Cytoplasmic and total cell extracts were analysed by SDS-PAGE
and immunoblotting with anti-Xpo2, anti-H3 and anti-GAPDH antibodies. (B) HeLa cells
were transfected with vectors encoding myc-SpvD or myc-SpvC. Cytoplasmic and total cell
extracts were analysed by SDS-PAGE and immunoblotting with anti-Xpo2, anti-H3 and anti-
GAPDH antibodies.
(TIF)
S1 Table. Levels of secreted TNF-α at 10 h post-uptake were quantified by ELISA in super-
natants of TLR4-/- BMMs infected with indicated strains of S. Typhimurium.
(DOCX)
S2 Table. Bacterial strains and plasmids used in this study.
(DOCX)
S3 Table. Oligonucleotide primers used in this study.
(DOCX)
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